LXRX
Lexicon Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +25.0% ·
flujo de acciones -0.7% ·
nuevas posiciones netas +20.0%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 68 | +16 | 115.42M | $276.97M | +20 | −4 |
| Q1 2026 | 53 | +1 | 96.42M | $150.42M | +5 | −4 |
| Q4 2025 | 51 | +1 | 73.64M | $84.69M | +2 | −1 |
| Q3 2025 | 13 | 0 | 62.78M | $84.76M | +2 | −2 |
| Q2 2025 | 10 | +2 | 57.50M | $54.38M | +4 | −2 |
| Q1 2025 | 5 | -2 | 7.56M | $3.49M | +1 | −3 |
| Q4 2024 | 7 | -2 | 16.13M | $11.91M | +1 | −3 |
| Q3 2024 | 8 | 0 | 7.88M | $12.37M | — | — |
| Q2 2024 | 8 | — | 12.44M | $20.91M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 38.14M | — | $36.07M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 38.14M | — | $36.07M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 38.14M | — | $36.07M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (pasivo) | 8.85M | — | $8.37M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (pasivo) | 8.85M | — | $8.37M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 3.35M | — | $3.17M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 3.35M | — | $3.17M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 3.35M | — | $3.17M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasivo) | 2.38M | -35.5% | $2.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasivo) | 2.38M | -35.5% | $2.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.64M | Nuevo | $1.55M | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasivo) | 818.62K | -68.6% | $774,170 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 486.67K | Nuevo | $460,248 | 0.0% | New | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 486.67K | Nuevo | $460,248 | 0.0% | New | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 486.67K | Nuevo | $460,248 | 0.0% | New | 1 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 403.92K | Nuevo | $381,989 | 0.0% | New | 1 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 23.72K | Nuevo | $22,435 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Millennium Management | $1.55M | 0.0% |
| Wellington Management | $460,248 | 0.0% |
| Wellington Management | $460,248 | 0.0% |
| Wellington Management | $460,248 | 0.0% |
| Two Sigma Investments | $381,989 | 0.0% |
| D. E. Shaw & Co. | $22,435 | 0.0% |
Posición cerrada
| T. Rowe Price | $43,000 | era 0.0% |
| Citadel Advisors | $187 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 136 tenedores, 323.38M acciones, $502.11M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.